Detalhe da pesquisa
1.
Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real-world setting: Results from the NEUF study.
Pediatr Blood Cancer
; 69(4): e29562, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35044079
2.
A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia.
Haematologica
; 104(10): 2028-2039, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30890593
3.
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Eur J Haematol
; 98(2): 112-120, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557853
4.
Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.
Eur J Haematol
; 94(2): 169-76, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039799
5.
Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity.
Acta Haematol
; 134(4): 215-28, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066765
6.
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.
Blood Cancer J
; 13(1): 2, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599847
7.
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study.
Drug Saf
; 42(1): 77-83, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30232740
8.
Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim.
Hematology
; 16(5): 274-7, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21902890